Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor Clearance

Immunity

Volumn 27, Issue 4, 2007, Pages 635-646

  Cao, Xuefang ^a   Cai, Sheng F ^a   Fehniger, Todd A ^a   Song, Jiling ^b   Collins, Lynne I ^b   Piwnica Worms, David R ^b   Ley, Timothy J ^a  

^a USA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CELLIMMUNO; MOLIMMUNO

Indexed keywords

GRANZYME B; PERFORIN; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CD8+ T LYMPHOCYTE; CELL DEATH; CELL FUNCTION; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; TUMOR CELL LINE; TUMOR GROWTH; WILD TYPE;

EID: 35449006679     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2007.08.014     Document Type: Article

References (45)

1. + T helper cells and hindered by naturally occurring T regulatory cells. J. Immunol. 174 (2005) 2591-2601
2. + regulatory T cells. Proc. Natl. Acad. Sci. USA 103 (2006) 5460-5465
3. Dunn G.P., Old L.J., and Schreiber R.D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21 (2004) 137-148
4. Dunn G.P., Old L.J., and Schreiber R.D. The three Es of cancer immunoediting. Annu. Rev. Immunol. 22 (2004) 329-360
5. Fehniger T.A., Cai S.F., Cao X., Bredemeyer A.J., Presti R.M., French A.R., and Ley T.J. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26 (2007) 798-811
6. + regulatory T cells. Nat. Immunol. 4 (2003) 330-336
7. + regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J. Exp. Med. 202 (2005) 1075-1085
8. + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174 (2005) 1783-1786
9. Goping I.S., Barry M., Liston P., Sawchuk T., Constantinescu G., Michalak K.M., Shostak I., Roberts D.L., Hunter A.M., Korneluk R., and Bleackley R.C. Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition. Immunity 18 (2003) 355-365
10. Gorelik L., and Flavell R.A. Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells. Nat. Med. 7 (2001) 1118-1122
11. Gross S., and Piwnica-Worms D. Real-time imaging of ligand-induced IKK activation in intact cells and in living mice. Nat. Methods 2 (2005) 607-614
12. Grossman W.J., Verbsky J.W., Barchet W., Colonna M., Atkinson J.P., and Ley T.J. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21 (2004) 589-601
13. Grossman W.J., Verbsky J.W., Tollefsen B.L., Kemper C., Atkinson J.P., and Ley T.J. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104 (2004) 2840-2848
14. Grundy M.A., Zhang T., and Sentman C.L. NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo. Cancer Immunol. Immunother. 56 (2007) 1153-1161
15. Heusel J.W., Wesselschmidt R.L., Shresta S., Russell J.H., and Ley T.J. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76 (1994) 977-987
16. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
17. Jans D.A., Sutton V.R., Jans P., Froelich C.J., and Trapani J.A. BCL-2 blocks perforin-induced nuclear translocation of granzymes concomitant with protection against the nuclear events of apoptosis. J. Biol. Chem. 274 (1999) 3953-3961
18. Karre K., Ljunggren H.G., Piontek G., and Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319 (1986) 675-678
19. Keefe D., Shi L., Feske S., Massol R., Navarro F., Kirchhausen T., and Lieberman J. Perforin triggers a plasma membrane-repair response that facilitates CTL induction of apoptosis. Immunity 23 (2005) 249-262
20. + T regulatory cells. Nat. Immunol. 4 (2003) 337-342
21. Kim S., Iizuka K., Aguila H.L., Weissman I.L., and Yokoyama W.M. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc. Natl. Acad. Sci. USA 97 (2000) 2731-2736
22. Kobayashi H., Aso H., Ishida N., Maeda H., Pollard R.B., and Suzuki F. Depletion of macrophages expressing I-J antigen results in efficient generation of alloreactive cytotoxic T lymphocytes. Cell. Immunol. 128 (1990) 589-602
23. Law P., Schwartz G.N., Alsop T., Haiber L.M., Smith D.M., and Dooley D.C. Removal of peripheral blood monocytes by phenylalanine methyl ester has no effect on the colony growth of hematopoietic progenitor cells. Int. J. Cell Cloning 7 (1989) 100-110
24. Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat. Rev. Immunol. 3 (2003) 361-370
25. Luo H., Li Q., O'Neal J., Kreisel F., Le Beau M.M., and Tomasson M.H. c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations. Blood 106 (2005) 2452-2461
26. Okada C.Y., Wong C.P., Denney D.W., and Levy R. TCR vaccines for active immunotherapy of T cell malignancies. J. Immunol. 159 (1997) 5516-5527
27. Pardoll D. Does the immune system see tumors as foreign or self?. Annu. Rev. Immunol. 21 (2003) 807-839
28. Revell P.A., Grossman W.J., Thomas D.A., Cao X., Behl R., Ratner J.A., Lu Z.H., and Ley T.J. Granzyme B and the downstream granzymes C and/or F are important for cytotoxic lymphocyte functions. J. Immunol. 174 (2005) 2124-2131
29. Rosen D., Li J.H., Keidar S., Markon I., Orda R., and Berke G. Tumor immunity in perforin-deficient mice: a role for CD95 (Fas/APO-1). J. Immunol. 164 (2000) 3229-3235
30. Russell J.H., and Ley T.J. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20 (2002) 323-370
31. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22 (2004) 531-562
32. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 (1995) 1151-1164
33. Screpanti V., Wallin R.P., Ljunggren H.G., and Grandien A. A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells. J. Immunol. 167 (2001) 2068-2073
34. Shi L., Mai S., Israels S., Browne K., Trapani J.A., and Greenberg A.H. Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GraB nuclear localization. J. Exp. Med. 185 (1997) 855-866
35. Shresta S., Goda P., Wesselschmidt R., and Ley T.J. Residual cytotoxicity and granzyme K expression in granzyme A-deficient cytotoxic lymphocytes. J. Biol. Chem. 272 (1997) 20236-20244
36. Smyth M.J., Thia K.Y., Street S.E., Cretney E., Trapani J.A., Taniguchi M., Kawano T., Pelikan S.B., Crowe N.Y., and Godfrey D.I. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191 (2000) 661-668
37. Smyth M.J., Thia K.Y., Street S.E., MacGregor D., Godfrey D.I., and Trapani J.A. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J. Exp. Med. 192 (2000) 755-760
38. Smyth M.J., Crowe N.Y., and Godfrey D.I. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Int. Immunol. 13 (2001) 459-463
39. Sutton V.R., Wowk M.E., Cancilla M., and Trapani J.A. Caspase activation by granzyme B is indirect, and caspase autoprocessing requires the release of proapoptotic mitochondrial factors. Immunity 18 (2003) 319-329
40. Thomas D.A., and Massague J. TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 8 (2005) 369-380
41. Turk M.J., Guevara-Patino J.A., Rizzuto G.A., Engelhorn M.E., Sakaguchi S., and Houghton A.N. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J. Exp. Med. 200 (2004) 771-782
42. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6 (2005) 338-344
43. Yamaguchi T., and Sakaguchi S. Regulatory T cells in immune surveillance and treatment of cancer. Semin. Cancer Biol. 16 (2006) 115-123
44. + T cells selectively kill B lymphocytes. Blood 107 (2006) 3925-3932
45. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 6 (2006) 295-307